Health technology assessment in Brazil

What do healthcare system players think about it?

Authors

  • Marcos Bosi Ferraz Grupo Interdepartamental de Economia da Saúde, Centro Paulista de Economia da Saúde, Universidade Federal de São Paulo
  • Patricia Coelho de Soárez Grupo Interdepartamental de Economia da Saúde, Centro Paulista de Economia da Saúde, Universidade Federal de São Paulo
  • Paola Zucchi Grupo Interdepartamental de Economia da Saúde, Centro Paulista de Economia da Saúde, Universidade Federal de São Paulo

Keywords:

Technology assessment, biomedical, Health facility administrators, Decision making, organizational, Health services administration, Health policy

Abstract

CONTEXT AND OBJECTIVES: The health technology assessment (HTA) process has been developed locally. The aim of this study was to describe, analyze and compare the opinions of participants in international health economics symposia about the HTA process used in Brazil. DESIGN AND SETTING: Observational cross-sectional study at the 2006 and 2008 International Health Economics Symposia, in São Paulo. METHODS: A structured questionnaire was applied. For the statistical analysis, the percentage distribution for each category was calculated, and variables were compared using tests for two-sample proportion hypotheses. RESULTS: Totals of 153 and 74 participants answered the 2006 and 2008 surveys, respectively. The response rate was better for the 2006 survey (67.1%) than for the 2008 survey (31.8%). Most interviewees were between the ages of 30 and 49 years and were managers in the healthcare system. Most of them considered that the current HTA process was incomplete and unable to meet the needs of the healthcare system. They mentioned the government, academia and experts as the three main groups of people who should be involved in the process, and selected efficiency/effectiveness, safety and disease relevance as the three main criteria to be considered in the HTA process. There is a trend towards developing decentralized regionalized HTA processes, with separate assessment and decision-making for the public and private systems. CONCLUSIONS: The HTA concept is well known. Healthcare system players feel that the process has methodological limitations. Additional surveys are needed to track the HTA process and its application in Brazil.

Downloads

Download data is not yet available.

Author Biographies

Marcos Bosi Ferraz, Grupo Interdepartamental de Economia da Saúde, Centro Paulista de Economia da Saúde, Universidade Federal de São Paulo

MD, PhD. Adjunct Professor, Department of Medicine, Universidade Federal de São Paulo — Escola Paulista de Medicina (Unifesp-EPM), São Paulo, Brazil.

Patricia Coelho de Soárez, Grupo Interdepartamental de Economia da Saúde, Centro Paulista de Economia da Saúde, Universidade Federal de São Paulo

DDS, MPH, PhD. Professor, Department of Preventive Medicine, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.

Paola Zucchi, Grupo Interdepartamental de Economia da Saúde, Centro Paulista de Economia da Saúde, Universidade Federal de São Paulo

MD, PhD. Affiliated Professor, Universidade Federal de São Paulo — Escola Paulista de Medicina, São Paulo, Brazil.

References

Banta HD, Luce BR. Health care technology and its assessment: an international perspective. New York: Oxford University Press; 1993.

Banta D, Jonsson E. History of HTA: Introduction. Int J Technol Assess Health Care. 2009;25 Suppl 1:1-6.

Banta D, Almeida RT. The development of health technology assessment in Brazil. Int J Technol Assess Health Care. 2009;25 Suppl 1:255-9.

Goldbaum M, Serruya SJ. O Ministério da Saúde e a política de ciência, tecnologia e inovação em saúde [The Brazilian Ministry of Health and science, technology, and innovation policy]. Cad Saude Publica = Rep Public Health. 2006;22(3):470-1.

Brasil. Ministério da Saúde. Secretaria de Ciência e Tecnologia. Insumos Estratégicos. Avaliação de Tecnologias em Saúde: institucionalização das ações no Ministério da Saúde [Health technology assessment: institutionalization of actions in the Brazilian Ministry of Health]. Rev Saude Publica = J Public Health. 2006;40(4):743-7.

Atallah AN. Evidence-based health technology assessments for the Brazilian National Health System (Sistema Único de Saúde, SUS) and for all. Sao Paulo Med J. 2009;127(2):59-60.

IATS. National Institute of Science and Technology for Health Technology Assessment. Mission. Available from: http://www.iats.com.br/eng/missao.php?id_cms_menu=2. Accessed in 2011 (Mar 22).

Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Ciência e Tecnologia. Diretrizes metodológicas: estudos de avaliação econômica de tecnologias em saúde. Brasília: Ministério da Saúde; 2009.

Ministério da Saúde. Consolidação da área de avaliação de tecnologias em saúde no Brasil [Consolidation of health technology assessment in Brazil]. Rev Saude Publica = J Public Health. 2010;44(2):381-3.

Banta D. Health technology assessment in Latin America and the Caribbean. Int J Technol Assess Health care. 2009;25 Suppl 1:253-4.

Banta HD. Medical technology and developing countries: the case of Brazil. Int J Health Serv. 1986;16(3):363-73.

Lehoux P, Blume S. Technology assessment and the sociopolitics of health technologies. J Health Polit Policy Law. 2000;25(6):1083-120.

Pichon-Riviere A, Augustovski F, Rubinstein A, Martí SG, Sullivan SD, Drummond MF. Health technology assessment for resource allocation decisions: are key principles relevant for Latin America? Int J Technol Assess Health Care. 2010;26(4):421-7.

Poulsen PB, Hørder M. [Assessment of medical technology in practice]. Ugeskr Laeger. 1998;160(35):5041-4.

Neumann PJ. Lessons for health technology assessment: it is not only about the evidence. Value Health. 2009;12 Suppl 2:S45-8.

Drummond M, Sorenson C. Nasty or nice? A perspective on the use of health technology assessment in the United Kingdom. Value Health. 2009;12 Suppl 2:S8-13.

Hailey D. The history of health technology assessment in Australia. Int J Technol Assess Health Care. 2009;25 Suppl 1:61-7.

Menon D, Stafinski T. Health technology assessment in Canada: 20 years strong? Value Health. 2009;12 Suppl 2:S14-9.

Lehoux P, Hivon M, Denis JL, Tailliez S. Health Technology Assessment in the Canadian Health Policy Arena: Examining Relationships between Evaluators and Stakeholders. SAGE. 2008;14(3):295-321. Available from: http://evi.sagepub.com/cgi/content/abstract/14/3/295. Accessed in 2011 (Feb 18).

Organization for Economic Co-Operation and Development. OECD. Directorate for Science, Technologies and Industry. Health Technologies and Decision Making. Available from: http://www.oecd.org/document/55/0,3343,en_2649_34537_35589431_1_1_1_1,00.html. Accessed in 2011 (Fev 18).

Sorenson C, Drummond M, Kristensen FB, Busse R. How can the impact of health technology assessments be enhanced? World Health Organization on behalf of the European Observatory on Health Systems and Policies; 2008. Available from: http://www.euro.who.int/data/assets/pdf_file/0019/73225/E93420.pdf. Accessed in 2011 (Feb 18).

Drummond M, Banta D. Health technology assessment in the United Kingdom. Int J Technol Assess Health Care. 2009;25 Suppl 1:178-81.

Abelson J, Giacomini M, Lehoux P, Gauvin FP. Bringing ‘the public’ into health technology assessment and coverage policy decisions: from principles to practice. Health Policy. 2007;82(1):37-50.

Wild C, Gibis B. Evaluations of health interventions in social insurance- based countries: Germany, the Netherlands, and Austria. Health Policy. 2003;63(2):187-96

Downloads

Published

2011-07-07

How to Cite

1.
Ferraz MB, Soárez PC de, Zucchi P. Health technology assessment in Brazil: What do healthcare system players think about it?. Sao Paulo Med J [Internet]. 2011 Jul. 7 [cited 2025 Mar. 9];129(4):198-205. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/1611

Issue

Section

Original Article